Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients

Denosumab is reported to increase bone mineral density (BMD) among haemodialysis patients; however, hypocalcaemia is a serious adverse effect among chronic kidney disease (CKD) patients. Identifying which patients will show greater improvement in BMD is important. We enrolled 84 haemodialysis patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Mayuko, Yasuda, Kaoru, Takahashi, Hiroshi, Kondo, Chika, Shirasawa, Yuichi, Ishimaru, Yuka, Sekiya, Yuka, Morozumi, Kunio, Maruyama, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095701/
https://www.ncbi.nlm.nih.gov/pubmed/35546172
http://dx.doi.org/10.1038/s41598-022-12029-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095701/
https://www.ncbi.nlm.nih.gov/pubmed/35546172
http://dx.doi.org/10.1038/s41598-022-12029-3

Ejemplares similares